Cargando…
Variability of Glycemic Outcomes and Insulin Requirements Throughout the Menstrual Cycle: A Qualitative Study on Women With Type 1 Diabetes Using an Open-Source Automated Insulin Delivery System
BACKGROUND: The impact of hormone dynamics throughout the menstrual cycle on insulin sensitivity represents a currently under-researched area. Despite therapeutic and technological advances, self-managing insulin therapy remains challenging for women with type 1 diabetes (T1D). METHODS: To investiga...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563528/ https://www.ncbi.nlm.nih.gov/pubmed/35254146 http://dx.doi.org/10.1177/19322968221080199 |
_version_ | 1785118355714211840 |
---|---|
author | Mewes, Darius Wäldchen, Mandy Knoll, Christine Raile, Klemens Braune, Katarina |
author_facet | Mewes, Darius Wäldchen, Mandy Knoll, Christine Raile, Klemens Braune, Katarina |
author_sort | Mewes, Darius |
collection | PubMed |
description | BACKGROUND: The impact of hormone dynamics throughout the menstrual cycle on insulin sensitivity represents a currently under-researched area. Despite therapeutic and technological advances, self-managing insulin therapy remains challenging for women with type 1 diabetes (T1D). METHODS: To investigate perceived changes in glycemic levels and insulin requirements throughout the menstrual cycle and different phases of life, we performed semi-structured interviews with 12 women with T1D who are using personalized open-source automated insulin delivery (AID) systems. Transcripts were analyzed using thematic analysis with an inductive, hypothesis-generating approach. RESULTS: Participants reported significant differences between the follicular phase, ovulation, and luteal phase of the menstrual cycle and also during puberty, pregnancy, and menopause. All participants reported increased comfort and safety since using AID, but were still required to manually adjust their therapy according to their cycle. A lack of information and awareness and limited guidance by health care providers were frequently mentioned. Although individual adjustment strategies exist, achieving optimum outcomes was still perceived as challenging. CONCLUSIONS: This study highlights that scientific evidence, therapeutic options, and professional guidance on female health-related aspects in T1D are insufficient to date. Further efforts are required to better inform people with T1D, as well as for health care professionals, researchers, medical device manufacturers, and regulatory bodies to better address female health needs in therapeutic advances. |
format | Online Article Text |
id | pubmed-10563528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-105635282023-10-11 Variability of Glycemic Outcomes and Insulin Requirements Throughout the Menstrual Cycle: A Qualitative Study on Women With Type 1 Diabetes Using an Open-Source Automated Insulin Delivery System Mewes, Darius Wäldchen, Mandy Knoll, Christine Raile, Klemens Braune, Katarina J Diabetes Sci Technol Original Articles BACKGROUND: The impact of hormone dynamics throughout the menstrual cycle on insulin sensitivity represents a currently under-researched area. Despite therapeutic and technological advances, self-managing insulin therapy remains challenging for women with type 1 diabetes (T1D). METHODS: To investigate perceived changes in glycemic levels and insulin requirements throughout the menstrual cycle and different phases of life, we performed semi-structured interviews with 12 women with T1D who are using personalized open-source automated insulin delivery (AID) systems. Transcripts were analyzed using thematic analysis with an inductive, hypothesis-generating approach. RESULTS: Participants reported significant differences between the follicular phase, ovulation, and luteal phase of the menstrual cycle and also during puberty, pregnancy, and menopause. All participants reported increased comfort and safety since using AID, but were still required to manually adjust their therapy according to their cycle. A lack of information and awareness and limited guidance by health care providers were frequently mentioned. Although individual adjustment strategies exist, achieving optimum outcomes was still perceived as challenging. CONCLUSIONS: This study highlights that scientific evidence, therapeutic options, and professional guidance on female health-related aspects in T1D are insufficient to date. Further efforts are required to better inform people with T1D, as well as for health care professionals, researchers, medical device manufacturers, and regulatory bodies to better address female health needs in therapeutic advances. SAGE Publications 2022-03-07 /pmc/articles/PMC10563528/ /pubmed/35254146 http://dx.doi.org/10.1177/19322968221080199 Text en © 2022 Diabetes Technology Society https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Articles Mewes, Darius Wäldchen, Mandy Knoll, Christine Raile, Klemens Braune, Katarina Variability of Glycemic Outcomes and Insulin Requirements Throughout the Menstrual Cycle: A Qualitative Study on Women With Type 1 Diabetes Using an Open-Source Automated Insulin Delivery System |
title | Variability of Glycemic Outcomes and Insulin Requirements Throughout the Menstrual Cycle: A Qualitative Study on Women With Type 1 Diabetes Using an Open-Source Automated Insulin Delivery System |
title_full | Variability of Glycemic Outcomes and Insulin Requirements Throughout the Menstrual Cycle: A Qualitative Study on Women With Type 1 Diabetes Using an Open-Source Automated Insulin Delivery System |
title_fullStr | Variability of Glycemic Outcomes and Insulin Requirements Throughout the Menstrual Cycle: A Qualitative Study on Women With Type 1 Diabetes Using an Open-Source Automated Insulin Delivery System |
title_full_unstemmed | Variability of Glycemic Outcomes and Insulin Requirements Throughout the Menstrual Cycle: A Qualitative Study on Women With Type 1 Diabetes Using an Open-Source Automated Insulin Delivery System |
title_short | Variability of Glycemic Outcomes and Insulin Requirements Throughout the Menstrual Cycle: A Qualitative Study on Women With Type 1 Diabetes Using an Open-Source Automated Insulin Delivery System |
title_sort | variability of glycemic outcomes and insulin requirements throughout the menstrual cycle: a qualitative study on women with type 1 diabetes using an open-source automated insulin delivery system |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563528/ https://www.ncbi.nlm.nih.gov/pubmed/35254146 http://dx.doi.org/10.1177/19322968221080199 |
work_keys_str_mv | AT mewesdarius variabilityofglycemicoutcomesandinsulinrequirementsthroughoutthemenstrualcycleaqualitativestudyonwomenwithtype1diabetesusinganopensourceautomatedinsulindeliverysystem AT waldchenmandy variabilityofglycemicoutcomesandinsulinrequirementsthroughoutthemenstrualcycleaqualitativestudyonwomenwithtype1diabetesusinganopensourceautomatedinsulindeliverysystem AT knollchristine variabilityofglycemicoutcomesandinsulinrequirementsthroughoutthemenstrualcycleaqualitativestudyonwomenwithtype1diabetesusinganopensourceautomatedinsulindeliverysystem AT raileklemens variabilityofglycemicoutcomesandinsulinrequirementsthroughoutthemenstrualcycleaqualitativestudyonwomenwithtype1diabetesusinganopensourceautomatedinsulindeliverysystem AT braunekatarina variabilityofglycemicoutcomesandinsulinrequirementsthroughoutthemenstrualcycleaqualitativestudyonwomenwithtype1diabetesusinganopensourceautomatedinsulindeliverysystem |